{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T21:37:56Z","timestamp":1774388276221,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T00:00:00Z","timestamp":1422057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"the Ministry of Education Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10549-015-3265-y","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T15:28:39Z","timestamp":1429630119000},"page":"597-605","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Viral transduction of the HER2-extracellular domain expands trastuzumab-based photoimmunotherapy for HER2-negative breast cancer cells"],"prefix":"10.1007","volume":"149","author":[{"given":"Kyoko","family":"Shimoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Noma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoto","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuri","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,24]]},"reference":[{"key":"3265_CR1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A et al (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science (New York, N.Y.) 244:707\u2013712","journal-title":"Science (New York, N.Y.)"},{"key":"3265_CR2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2008.19.9844","volume":"28","author":"S Dawood","year":"2010","unstructured":"Dawood S, Broglio K, Buzdar AU, Hortobagyi GN, Giordano SH (2010) Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol 28:92\u201398. doi: 10.1200\/jco.2008.19.9844","journal-title":"J Clin Oncol"},{"key":"3265_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"3265_CR4","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/sj.bjc.6601881","volume":"90","author":"J Carlsson","year":"2004","unstructured":"Carlsson J, Nordgren H, Sjostrom J, Wester K, Villman K, Bengtsson NO, Ostenstad B, Lundqvist H, Blomqvist C (2004) HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer 90:2344\u20132348. doi: 10.1038\/sj.bjc.6601881","journal-title":"Br J Cancer"},{"key":"3265_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncponc0509","volume":"3","author":"R Nahta","year":"2006","unstructured":"Nahta R, Yu D, Hung MC, Hortobagyi GN, Esteva FJ (2006) Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. Nat Clin Pract Oncol 3:269\u2013280. doi: 10.1038\/ncponc0509","journal-title":"Nat Clin Pract Oncol"},{"key":"3265_CR6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783\u2013792. doi: 10.1056\/nejm200103153441101","journal-title":"N Engl J Med"},{"key":"3265_CR7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","volume":"365","author":"D Slamon","year":"2011","unstructured":"Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J (2011) Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med 365:1273\u20131283. doi: 10.1056\/NEJMoa0910383","journal-title":"N Engl J Med"},{"key":"3265_CR8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","volume":"17","author":"M Mitsunaga","year":"2011","unstructured":"Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H (2011) Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med 17:1685\u20131691. doi: 10.1038\/nm.2554","journal-title":"Nat Med"},{"key":"3265_CR9","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00262-012-1249-x","volume":"61","author":"R Yoshida","year":"2012","unstructured":"Yoshida R, Tazawa H, Hashimoto Y, Yano S, Onishi T, Sasaki T, Shirakawa Y, Kishimoto H, Uno F, Nishizaki M, Kagawa S, Fujiwara T (2012) Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells. Cancer Immunol Immunother 61:1905\u20131916. doi: 10.1007\/s00262-012-1249-x","journal-title":"Cancer Immunol Immunother"},{"key":"3265_CR10","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1158\/0008-5472.CAN-04-1335","volume":"64","author":"T Umeoka","year":"2004","unstructured":"Umeoka T, Kawashima T, Kagawa S, Teraishi F, Taki M, Nishizaki M, Kyo S, Nagai K, Urata Y, Tanaka N, Fujiwara T (2004) Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene. Cancer research 64:6259\u20136265. doi: 10.1158\/0008-5472.can-04-1335","journal-title":"Cancer research"},{"key":"3265_CR11","first-page":"3330","volume":"61","author":"S Kagawa","year":"2001","unstructured":"Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B (2001) Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 61:3330\u20133338","journal-title":"Cancer Res"},{"key":"3265_CR12","first-page":"1141","volume":"35","author":"V Papanikolaou","year":"2009","unstructured":"Papanikolaou V, Iliopoulos D, Dimou I, Dubos S, Tsougos I, Theodorou K, Kitsiou-Tzeli S, Tsezou A (2009) The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells. Int J Oncol 35:1141\u20131149","journal-title":"Int J Oncol"},{"key":"3265_CR13","author":"GW Sledge","year":"2014","unstructured":"Sledge GW, Mamounas EP, Hortobagyi GN, Burstein HJ, Goodwin PJ, Wolff AC (2014) Past, present, and future challenges in breast cancer treatment. J Clin Oncol. doi: 10.1200\/jco.2014.55.4139","journal-title":"J Clin Oncol"},{"key":"3265_CR14","first-page":"35","volume":"4","author":"K Subik","year":"2010","unstructured":"Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung MC, Bonfiglio T, Hicks DG, Tang P (2010) The Expression Patterns of ER, PR, HER2, CK5\/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer 4:35\u201341","journal-title":"Breast Cancer"},{"key":"3265_CR15","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/MCB.9.3.1165","volume":"9","author":"RM Hudziak","year":"1989","unstructured":"Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM, Ullrich A (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol 9:1165\u20131172","journal-title":"Mol Cell Biol"},{"key":"3265_CR16","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1158\/0008-5472.CAN-08-1776","volume":"68","author":"GD Lewis Phillips","year":"2008","unstructured":"Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Blattler WA, Lambert JM, Chari RV, Lutz RJ, Wong WL, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, Sliwkowski MX (2008) Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res 68:9280\u20139290. doi: 10.1158\/0008-5472.can-08-1776","journal-title":"Cancer Res"},{"key":"3265_CR17","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1158\/0008-5472.CAN-12-1298","volume":"72","author":"T Nakajima","year":"2012","unstructured":"Nakajima T, Sano K, Mitsunaga M, Choyke PL, Kobayashi H (2012) Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. Cancer Res 72:4622\u20134628. doi: 10.1158\/0008-5472.can-12-1298","journal-title":"Cancer Res"},{"key":"3265_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/1471-2407-12-345","volume":"12","author":"M Mitsunaga","year":"2012","unstructured":"Mitsunaga M, Nakajima T, Sano K, Kramer-Marek G, Choyke PL, Kobayashi H (2012) Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy. BMC Cancer 12:345. doi: 10.1186\/1471-2407-12-345","journal-title":"BMC Cancer"},{"key":"3265_CR19","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/bcr3167","volume":"14","author":"K Sano","year":"2012","unstructured":"Sano K, Mitsunaga M, Nakajima T, Choyke PL, Kobayashi H (2012) In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores. Breast Cancer Res 14:R61. doi: 10.1186\/bcr3167","journal-title":"Breast Cancer Res"},{"key":"3265_CR20","first-page":"60","volume":"26","author":"MX Sliwkowski","year":"1999","unstructured":"Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM, Fox JA (1999) Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol 26:60\u201370","journal-title":"Semin Oncol"},{"key":"3265_CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMra043186","volume":"357","author":"CA Hudis","year":"2007","unstructured":"Hudis CA (2007) Trastuzumab\u2013mechanism of action and use in clinical practice. N Engl J Med 357:39\u201351. doi: 10.1056\/NEJMra043186","journal-title":"N Engl J Med"},{"key":"3265_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-60761-697-9_10","volume":"635","author":"K Berg","year":"2010","unstructured":"Berg K, Weyergang A, Prasmickaite L, Bonsted A, Hogset A, Strand MT, Wagner E, Selbo PK (2010) Photochemical internalization (PCI): a technology for drug delivery. Methods Mol Biol 635:133\u2013145. doi: 10.1007\/978-1-60761-697-9_10","journal-title":"Methods Mol Biol"},{"key":"3265_CR23","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.bbagen.2012.08.027","volume":"1820","author":"MB Berstad","year":"2012","unstructured":"Berstad MB, Weyergang A, Berg K (2012) Photochemical internalization (PCI) of HER2-targeted toxins: synergy is dependent on the treatment sequence. Biochim Biophys Acta 1820:1849\u20131858. doi: 10.1016\/j.bbagen.2012.08.027","journal-title":"Biochim Biophys Acta"},{"key":"3265_CR24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jconrel.2013.07.011","volume":"172","author":"SC Owen","year":"2013","unstructured":"Owen SC, Patel N, Logie J, Pan G, Persson H, Moffat J, Sidhu SS, Shoichet MS (2013) Targeting HER2\u00a0+\u00a0breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles. J Control Release 172:395\u2013404. doi: 10.1016\/j.jconrel.2013.07.011","journal-title":"J Control Release"},{"key":"3265_CR25","author":"N Shirasu","year":"2014","unstructured":"Shirasu N, Yamada H, Shibaguchi H, Kuroki M, Kuroki M (2014) Potent and specific antitumor effect of CEA-targeted photoimmunotherapy. Int J Cancer. doi: 10.1002\/ijc.28907","journal-title":"Int J Cancer"},{"key":"3265_CR26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4161\/cbt.11.9.15045","volume":"11","author":"JT Garrett","year":"2011","unstructured":"Garrett JT, Arteaga CL (2011) Resistance to HER2-directed antibodies and tyrosine kinase inhibitors: mechanisms and clinical implications. Cancer Biol Ther 11:793\u2013800","journal-title":"Cancer Biol Ther"},{"key":"3265_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nm.2309","volume":"17","author":"S Zhang","year":"2011","unstructured":"Zhang S, Huang WC, Li P, Guo H, Poh SB, Brady SW, Xiong Y, Tseng LM, Li SH, Ding Z, Sahin AA, Esteva FJ, Hortobagyi GN, Yu D (2011) Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways. Nat Med 17:461\u2013469. doi: 10.1038\/nm.2309","journal-title":"Nat Med"},{"key":"3265_CR28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2010.29.5865","volume":"29","author":"HA Burris 3rd","year":"2011","unstructured":"Burris HA 3rd, Rugo HS, Vukelja SJ, Vogel CL, Borson RA, Limentani S, Tan-Chiu E, Krop IE, Michaelson RA, Girish S, Amler L, Zheng M, Chu YW, Klencke B, O\u2019Shaughnessy JA (2011) Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy. J Clin Oncol 29:398\u2013405. doi: 10.1200\/jco.2010.29.5865","journal-title":"J Clin Oncol"},{"key":"3265_CR29","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-10-0987","volume":"16","author":"JR Junutula","year":"2010","unstructured":"Junutula JR, Flagella KM, Graham RA, Parsons KL, Ha E, Raab H, Bhakta S, Nguyen T, Dugger DL, Li G, Mai E, Lewis Phillips GD, Hiraragi H, Fuji RN, Tibbitts J, Vandlen R, Spencer SD, Scheller RH, Polakis P, Sliwkowski MX (2010) Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer. Clinical Cancer Res 16:4769\u20134778. doi: 10.1158\/1078-0432.ccr-10-0987","journal-title":"Clinical Cancer Res"},{"key":"3265_CR30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/86684","volume":"19","author":"R Weissleder","year":"2001","unstructured":"Weissleder R (2001) A clearer vision for in vivo imaging. Nat Non-viral Biotechnol 19:316\u2013317. doi: 10.1038\/86684","journal-title":"Nat Non-viral Biotechnol"},{"key":"3265_CR31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/bc200648m","volume":"23","author":"M Mitsunaga","year":"2012","unstructured":"Mitsunaga M, Nakajima T, Sano K, Choyke PL, Kobayashi H (2012) Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate. Bioconjugate Chem 23:604\u2013609. doi: 10.1021\/bc200648m","journal-title":"Bioconjugate Chem"},{"key":"3265_CR32","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1158\/1535-7163.MCT-13-0633","volume":"13","author":"K Sano","year":"2014","unstructured":"Sano K, Nakajima T, Choyke PL, Kobayashi H (2014) The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy. Mol Cancer Ther 13:426\u2013432. doi: 10.1158\/1535-7163.mct-13-0633","journal-title":"Mol Cancer Ther"},{"key":"3265_CR33","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1200\/JCO.2001.19.6.1750","volume":"19","author":"M Schuler","year":"2001","unstructured":"Schuler M, Herrmann R, De Greve JL, Stewart AK, Gatzemeier U, Stewart DJ, Laufman L, Gralla R, Kuball J, Buhl R, Heussel CP, Kommoss F, Perruchoud AP, Shepherd FA, Fritz MA, Horowitz JA, Huber C, Rochlitz C (2001) Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol 19:1750\u20131758","journal-title":"J Clin Oncol"},{"key":"3265_CR34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/hum.2010.227","volume":"22","author":"E Smith","year":"2011","unstructured":"Smith E, Breznik J, Lichty BD (2011) Strategies to enhance viral penetration of solid tumors. Hum Gene Ther 22:1053\u20131060. doi: 10.1089\/hum.2010.227","journal-title":"Hum Gene Ther"},{"key":"3265_CR35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG (2014) vectors for gene-based therapy. Nature reviews. Genetics 15:541\u2013555. doi: 10.1038\/nrg3763","journal-title":"Nature reviews. Genetics"},{"key":"3265_CR36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nm1404","volume":"12","author":"H Kishimoto","year":"2006","unstructured":"Kishimoto H, Kojima T, Watanabe Y, Kagawa S, Fujiwara T, Uno F, Teraishi F, Kyo S, Mizuguchi H, Hashimoto Y, Urata Y, Tanaka N, Fujiwara T (2006) In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus. Nat Med 12:1213\u20131219. doi: 10.1038\/nm1404","journal-title":"Nat Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3265-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3265-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T18:11:02Z","timestamp":1566583862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3265-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,24]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3265"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3265-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,24]]}}}